Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Jun Yu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lipids in Health and Disease|June 25, 2020
The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional studyBu-Yuan Dong, Yu-Qing Mao, Zheng-Yang Li, et al.
Molecular and Clinical Oncology|December 4, 2014
Long non-coding RNAs and hepatocellular carcinomaFu-Jun Yu, Jian-Jian Zheng, Pei-Hong Dong, et al.
Zhonghua Yi Xue Za Zhi|July 19, 2013
[Expression of miRNA-29b and its clinical significances in primary hepatic carcinoma]Jian-jian Zheng, Fu-jun Yu, Pei-hong Dong, et al.
International Journal of Molecular Medicine|April 8, 2010
Down-regulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cellsFu Jun Yu, Pei Hong Dong, Xu Fei Fan, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2011
miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein levelShen-meng Gao, Chong-yun Xing, Chi-qi Chen, et al.
Experimental Hematology|November 1, 2012
Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasmsShen-meng Gao, Chi-qi Chen, Lu-yao Wang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patientsLiang Shi, Li-Li Wu, Jian-Rong Yang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lipids in Health and Disease|June 25, 2020
The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional studyBu-Yuan Dong, Yu-Qing Mao, Zheng-Yang Li, et al.
Molecular and Clinical Oncology|December 4, 2014
Long non-coding RNAs and hepatocellular carcinomaFu-Jun Yu, Jian-Jian Zheng, Pei-Hong Dong, et al.
Zhonghua Yi Xue Za Zhi|July 19, 2013
[Expression of miRNA-29b and its clinical significances in primary hepatic carcinoma]Jian-jian Zheng, Fu-jun Yu, Pei-hong Dong, et al.
International Journal of Molecular Medicine|April 8, 2010
Down-regulation of angiotensin II by shRNA reduces collagen synthesis in hepatic stellate cellsFu Jun Yu, Pei Hong Dong, Xu Fei Fan, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2011
miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein levelShen-meng Gao, Chong-yun Xing, Chi-qi Chen, et al.
Experimental Hematology|November 1, 2012
Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasmsShen-meng Gao, Chi-qi Chen, Lu-yao Wang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
Serum peroxiredoxin3 is a useful biomarker for early diagnosis and assessemnt of prognosis of hepatocellular carcinoma in Chinese patientsLiang Shi, Li-Li Wu, Jian-Rong Yang, et al.
Pageof 1